Thyrotropin aggravates atherosclerosis by promoting macrophage inflammation in plaques

Chongbo Yang,Ming Lu,Wenbin Chen,Zhao He,Xu Hou,Mei Feng,Hongjia Zhang,Tao Bo,Xiaoming Zhou,Yong Yu,Haiqing Zhang,Meng Zhao,Laicheng Wang,Chunxiao Yu,Ling Gao,Wenjian Jiang,Qunye Zhang,Jiajun Zhao

Published 2019 in Journal of Experimental Medicine

ABSTRACT

Subclinical hypothyroidism is associated with cardiovascular diseases, yet the underlying mechanism remains largely unknown. Herein, in a common population (n = 1,103), TSH level was found to be independently correlated with both carotid plaque prevalence and intima-media thickness. Consistently, TSH receptor ablation in ApoE−/− mice attenuated atherogenesis, accompanied by decreased vascular inflammation and macrophage burden in atherosclerotic plaques. These results were also observed in myeloid-specific Tshr-deficient ApoE−/− mice, which indicated macrophages to be a critical target of the proinflammatory and atherogenic effects of TSH. In vitro experiments further revealed that TSH activated MAPKs (ERK1/2, p38&agr;, and JNK) and I&kgr;B/p65 pathways in macrophages and increased inflammatory cytokine production and their recruitment of monocytes. Thus, the present study has elucidated the new mechanisms by which TSH, as an independent risk factor of atherosclerosis, aggravates vascular inflammation and contributes to atherogenesis.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-62 of 62 references · Page 1 of 1

CITED BY

Showing 1-53 of 53 citing papers · Page 1 of 1